Current Pharmaceutical Design
Title: Preface
Volume: 6 Issue: 1
Author(s): Dargo R. Sliskovic and Bruce D. Roth
Affiliation:
Export Options
About this article
Cite this article as:
Sliskovic R. Dargo and Roth D. Bruce, Preface, Current Pharmaceutical Design 2000; 6 (1) . https://dx.doi.org/10.2174/13816128100060100ii
DOI https://dx.doi.org/10.2174/13816128100060100ii |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
15
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Development and Validation of a New HPLC Method For the Detection of 5- Fluorouracil in Mobile Phase and in Plasma
Current Pharmaceutical Analysis The Role of Fibroblast Growth Factors in Tumor Growth
Current Cancer Drug Targets Sugar Based Biopolymers in Nanomedicine; New Emerging Era for Cancer Imaging and Therapy
Current Topics in Medicinal Chemistry Combinatorial Synthesis and Characterization of New Asymmetric Porphyrins as Potential Photosensitizers in Photodynamic Therapy
Combinatorial Chemistry & High Throughput Screening Epidermal Growth Factor Receptor Targeting in Non-Small Cell Lung Cancer: Revisiting Different Strategies Against the Same Target
Current Drug Targets A Fast and Efficient Chemiluminescence Method for Determination and Pharmacokinetic Study of Paclitaxel in Rat Plasma
Current Pharmaceutical Analysis Exploiting Internal Ribosome Entry Sites in Gene Therapy Vector Design
Current Gene Therapy miRNA 21: Diagnostic Prognostic and Therapeutic Marker for Oral Cancer
MicroRNA New Generation of Oncolytic Herpes Virus
Current Cancer Therapy Reviews Carbohydrates: Potential Sweet Tools Against Cancer
Current Medicinal Chemistry Death Receptor Ligands: New Strategies for Combined Treatment with Ionizing Radiation
Current Medicinal Chemistry - Anti-Cancer Agents Targeting MDM4 as a Novel Therapeutic Approach for Hematologic Malignancies
Current Cancer Drug Targets Methotrexate-Induced Pneumonitis: Heterogeneity of Bronchoalveolar Lavage and Differences between Cancer and Rheumatoid Arthritis
Inflammation & Allergy - Drug Targets (Discontinued) Current View on the Mechanism of Action of Perifosine in Cancer
Anti-Cancer Agents in Medicinal Chemistry Phosphatidylinositol 3-kinase Signaling as a Therapeutic Target for Cervical Cancer
Current Cancer Drug Targets Systemic Approach to the Study of Complex Bone Disorders at the Whole- Genome Level
Current Genomics Transcriptional Regulation of mPGES1 in Cancer: An Alternative Approach to Drug Discovery?
Current Drug Targets LRRC4 Inhibits Glioma Cell Growth and Invasion Through a miR-185- Dependent Pathway
Current Cancer Drug Targets MicroRNAs as Biomarkers for Birth Defects
MicroRNA DNA Methylation Based Biomarkers in Non-Invasive Cancer Screening
Current Molecular Medicine